News
Americans wonder: Which COVID-19 booster is best?
October 26, 2021
Americans recently were handed a big decision when it comes to getting a COVID-19 vaccine booster.
![1]()
News
FDA approves combo pill for severe, acute pain
October 19, 2021
Seglentis contains 56 mg of celecoxib and 44 mg of tramadol.
News
Valneva jumps on positive results for COVID-19 vaccine candidate
October 19, 2021
The vaccine generated similar seroconversion rates and slightly higher neutralizing antibody titers compared with AstraZeneca’s Vaxzevria.
News
Some diabetes drugs may lower risk of severe COVID-19 outcomes
October 19, 2021
Glucose-regulating medications may improve outcomes in COVID-19 patients with type 2 diabetes, a multinational retrospective cohort study suggests.
News
AstraZeneca antibody cocktail study shows success treating COVID-19
October 12, 2021
The drug reduced the risk of severe COVID-19 or death by 50% in non-hospitalized patients who have had symptoms for seven days or less.
News
Rivaroxaban’s single daily dose may lead to higher bleeding risk than other DOACs
October 11, 2021
Corroborating previous studies, Iceland researchers report that rivaroxaban poses the highest risk of GI bleeding, compared with other DOACs.
![1]()
News
New reports help nail down myocarditis risk with COVID-19 vaccine
October 11, 2021
Myocarditis linked to the two mRNA SARS-CoV-2 vaccines is rare, usually mild and self-limited, and a lot less likely than the usually more severe cases seen in COVID-19.
News
Merck seeks FDA authorization for antiviral COVID-19 pill
October 11, 2021
If the FDA grants authorization, the drug would be the first oral antiviral treatment for COVID-19.
News
Antibody cocktail reduces chance of developing COVID
October 4, 2021
“This is the first long-acting combination of monoclonal antibodies that represents a potential new option to augment COVID-19 prevention.”
News
Merck to seek FDA OK for its COVID pill after trial stopped early
October 4, 2021
“The availability of a well-tolerated, effective oral antiviral will be particularly useful in supplementing vaccination as a means to reduce the proportion of patients needing hospital care.”
